CDNS — Cadence Design Systems, Inc.

Sell-side tone is Bullish: 26 Buys vs 1 Sell, consensus price target $404.56, and recent average target $391.83. Q2 FY26 non-GAAP EPS beat, revenue grew 24% year-over-year, and FY26 guidance was raised. The actual tape is weak — price down 3.2% at the latest close, -13.5% over one week, RSI 31.7 — so the bullish consensus is colliding with macro-driven technical selling, not a fundamental downgrade.

Revenue has accelerated, not just stabilized: quarterly revenue grew from $1.274B in Q2 FY25 to $1.584B in Q2 FY26, roughly 24% year-over-year, versus ~19-20% growth in the prior two quarters; FY26 guidance of $6.26-6.34B implies ~19% full-year growth. Non-GAAP operating margin expanded to 45.5% from 42.8%, while GAAP op margin slipped slightly to 28.4% from 29.0% — but Q2 FY25 GAAP EPS was depressed to $0.59 by noise, while Q2 FY26 GAAP EPS was $1.33. The record $8.1B contracted backlog and $634.9M quarterly operating cash flow support an inflection rather than a one-quarter blip.

On trailing GAAP EPS of $5.05, the P/E is 58.3x, below its 5-year average of 69.8x; trailing P/S of 13.9x is also below the 16.2x 5-year average. Using FY26 consensus EPS around $8.14, forward P/E is roughly 36.3x with a PEG near 1.6. In absolute terms the stock is not cheap, but relative to its own history and its growth rate it is the least expensive it has been in years — a de-rated quality compounder, not a value stock.

Price fell about 21.7% over three months while earnings estimates were being raised after a beat-and-raise. The market is currently pricing in downside from macro fears and export-control risk rather than weak execution. If Cadence converts its record backlog and delivers guided growth, the stock is likely understating earnings power; if China restrictions or an AI capex pause push backlog slippage, the compression will have been justified.

As of 2026-09-04, RSI is 31.7, which is oversold; price is -8.6% below the 20-day SMA, -13.8% below the 50-day SMA, and -10.0% below the 200-day SMA. One-week return is -13.5% and three-month return is -21.7%, within a 52-week range of $262.75-$416.69. This is a downtrend that has reached oversold levels — a possible bounce setup, but no confirmed reversal until it reclaims the 20-day or 50-day averages, so scale-in rather than one-lump entry is more prudent.

• AI infrastructure and custom-silicon buildout are a structural tailwind for EDA demand.
• High interest rates and multiple compression are pressuring long-duration, high-multiple software stocks.
• U.S.-China export controls remain a real risk despite very strong reported Asia/China growth.
• Semiconductor capex cycles and hyperscaler budget decisions drive near-term demand volatility.
• Hexagon design-and-engineering integration and fierce EDA competition from Synopsys and Siemens shape the competitive backdrop.

• Q3 FY26 earnings in late October 2026: backlog conversion and any further guidance raise.
• Continued AI/EDA design wins, including the NVIDIA Grace/Blackwell collaboration and ChipStack adoption.
• Expansion of agentic AI and AI-for-design platforms into larger contracts.
• Macro stabilization or rate relief that reverses the current multiple compression.

• Tightening U.S.-China export controls hurting a significant Asia/China growth contributor.
• AI/hyperscaler capex pause or a broader semiconductor downturn reducing design starts.
• Persistent high interest rates keeping the multiple under pressure even if fundamentals hold.
• Backlog conversion or integration execution risk, particularly with the Hexagon acquisition.
• Competitive response from Synopsys/Siemens or disruptive AI-native design-tool entrants.

Good business now trading at a better price than most of the past five years. CDNS combines roughly 85-88% gross margins, 19-24% revenue growth, a record contracted backlog, and a durable EDA duopoly position, while the 2026 selloff has taken valuation from rich to merely expensive. On a 1-3 year view the asymmetry is positive, though near-term momentum is still down and this is analysis, not personalized advice.

I blend two cross-checks: 45x FY26 consensus EPS of $8.14 gives about $366, and the 5-year average P/S multiple of 16.16 applied to FY26 consensus revenue of $6.319B with roughly 275.4M shares gives about $371. $369 is the rounded midpoint, intentionally below the Street consensus target of about $405 but still implying meaningful upside from the current $295.26 price.